Gefitinib Plus Chemotherapy vs Gefitinib Alone for Untreated EGFR-Mutant NSCLC With Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open-Label, Randomized, Multicenter, Phase 3 Study
JAMA Netw Open 2023 Feb 01;6(2)e2255050, X Hou, M Li, G Wu, W Feng, J Su, H Jiang, G Jiang, J Chen, B Zhang, Z You, Q Liu, L ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.